Literature DB >> 26349406

Decreased expression of nociceptin/orphanin FQ in the dorsal anterior cingulate cortex of suicides.

Pierre-Eric Lutz1, Yi Zhou1, Aurélie Labbe2, Naguib Mechawar2, Gustavo Turecki3.   

Abstract

The nociceptin/orphanin FQ (N/OFQ)-Nociceptin Opiod-like Peptide (NOP) receptor system is a critical mediator of physiological and pathological processes involved in emotional regulation and drug addiction. As such, this system may be an important biological substrate underlying psychiatric conditions that contribute to the risk of suicide. Thus, the goal of the present study was to characterize changes in human N/OFQ and NOP signaling as a function of depression, addiction and suicide. We quantified the expression of N/OFQ and NOP by RT-PCR in the anterior insula, the mediodorsal thalamus, and the dorsal anterior cingulate cortex (dACC) from a large sample of individuals who died by suicide and matched psychiatrically-healthy controls. Suicides displayed an 18% decrease in the expression of N/OFQ in the dACC that was not accounted for by current depressive or substance use disorders at the time of death. Therefore, our results suggest that dysregulation of the N/OFQ-NOP system may contribute to the neurobiology of suicide, a hypothesis that warrants further exploration.
Copyright © 2015 Elsevier B.V. and ECNP. All rights reserved.

Entities:  

Keywords:  Addiction; Anterior Cingulate Cortex; Depression; Nociceptin Opiod-like Peptide receptor; Nociceptin/Orphanin FQ; Suicide

Mesh:

Substances:

Year:  2015        PMID: 26349406      PMCID: PMC4655195          DOI: 10.1016/j.euroneuro.2015.08.015

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  29 in total

1.  Nociceptin receptor antagonists display antidepressant-like properties in the mouse forced swimming test.

Authors:  John P Redrobe; Girolamo Calo'; Domenico Regoli; Rémi Quirion
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2001-12-20       Impact factor: 3.000

2.  Regionally selective increases in mu opioid receptor density in the brains of suicide victims.

Authors:  R Gross-Isseroff; K A Dillon; M Israeli; A Biegon
Journal:  Brain Res       Date:  1990-10-22       Impact factor: 3.252

Review 3.  Emotional processing in anterior cingulate and medial prefrontal cortex.

Authors:  Amit Etkin; Tobias Egner; Raffael Kalisch
Journal:  Trends Cogn Sci       Date:  2010-12-16       Impact factor: 20.229

4.  Risk factors for suicide completion in major depression: a case-control study of impulsive and aggressive behaviors in men.

Authors:  A Dumais; A D Lesage; M Alda; G Rouleau; M Dumont; N Chawky; M Roy; J J Mann; C Benkelfat; Gustavo Turecki
Journal:  Am J Psychiatry       Date:  2005-11       Impact factor: 18.112

5.  Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women.

Authors:  Susan E Kennedy; Robert A Koeppe; Elizabeth A Young; Jon-Kar Zubieta
Journal:  Arch Gen Psychiatry       Date:  2006-11

6.  Nociceptin/orphanin FQ content is decreased in forebrain neurones during acute stress.

Authors:  D P Devine; M T Hoversten; Y Ueda; H Akil
Journal:  J Neuroendocrinol       Date:  2003-01       Impact factor: 3.627

Review 7.  Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs.

Authors:  Elaine Cristina Gavioli; Girolamo Calo'
Journal:  Pharmacol Ther       Date:  2013-05-24       Impact factor: 12.310

8.  Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice.

Authors:  E C Gavioli; C W Vaughan; G Marzola; R Guerrini; V A Mitchell; S Zucchini; T C M De Lima; G A Rae; S Salvadori; D Regoli; G Calo'
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-05-25       Impact factor: 3.000

9.  Association of in vivo κ-opioid receptor availability and the transdiagnostic dimensional expression of trauma-related psychopathology.

Authors:  Robert H Pietrzak; Mika Naganawa; Yiyun Huang; Stefani Corsi-Travali; Ming-Qiang Zheng; Murray B Stein; Shannan Henry; Keunpoong Lim; Jim Ropchan; Shu-Fei Lin; Richard E Carson; Alexander Neumeister
Journal:  JAMA Psychiatry       Date:  2014-11       Impact factor: 21.596

10.  Nociceptin/orphanin FQ and NOP receptor gene regulation after acute or repeated social defeat stress.

Authors:  Megan K Green; Darragh P Devine
Journal:  Neuropeptides       Date:  2009-08-31       Impact factor: 3.286

View more
  6 in total

1.  Nociceptin Receptors in Alcohol Use Disorders: A Positron Emission Tomography Study Using [11C]NOP-1A.

Authors:  Rajesh Narendran; Roberto Ciccocioppo; Brian Lopresti; Jennifer Paris; Michael L Himes; N Scott Mason
Journal:  Biol Psychiatry       Date:  2017-05-31       Impact factor: 13.382

Review 2.  Neuropathology of suicide: recent findings and future directions.

Authors:  P-E Lutz; N Mechawar; G Turecki
Journal:  Mol Psychiatry       Date:  2017-07-11       Impact factor: 15.992

3.  Neuropathic pain promotes adaptive changes in gene expression in brain networks involved in stress and depression.

Authors:  Giannina Descalzi; Vasiliki Mitsi; Immanuel Purushothaman; Sevasti Gaspari; Kleopatra Avrampou; Yong-Hwee Eddie Loh; Li Shen; Venetia Zachariou
Journal:  Sci Signal       Date:  2017-03-21       Impact factor: 8.192

4.  Analysis of key genes and micro-RNA-mRNA regulatory networks in women with ulcerative interstitial cystitis/pain bladder syndrome.

Authors:  Shengzhuo Liu; Shijian Feng; Deyi Luo
Journal:  Int Urogynecol J       Date:  2018-11-19       Impact factor: 2.894

5.  Global long non-coding RNA expression in the rostral anterior cingulate cortex of depressed suicides.

Authors:  Yi Zhou; Pierre-Eric Lutz; Yu Chang Wang; Jiannis Ragoussis; Gustavo Turecki
Journal:  Transl Psychiatry       Date:  2018-10-18       Impact factor: 6.222

Review 6.  Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders.

Authors:  Jamie A Burns; Danielle S Kroll; Dana E Feldman; Christopher Kure Liu; Peter Manza; Corinde E Wiers; Nora D Volkow; Gene-Jack Wang
Journal:  Front Psychiatry       Date:  2019-09-18       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.